Page last updated: 2024-10-17

phosphonoacetic acid and Hepatic Encephalopathy

phosphonoacetic acid has been researched along with Hepatic Encephalopathy in 1 studies

Phosphonoacetic Acid: A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent.
phosphonoacetic acid : A member of the class of phosphonic acids that is phosphonic acid in which the hydrogen attached to the phosphorous is replaced by a carboxymethyl group.

Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Price, JS1
France, AJ1
Moaven, LD1
Welsby, PD1

Other Studies

1 other study available for phosphonoacetic acid and Hepatic Encephalopathy

ArticleYear
Foscarnet in fulminant hepatitis B.
    Lancet (London, England), 1986, Nov-29, Volume: 2, Issue:8518

    Topics: Adolescent; Antiviral Agents; Foscarnet; Hepatic Encephalopathy; Hepatitis B; Humans; Organophosphor

1986